Liver Vessel Enhancement by Gd-BOPTA and Gd-EOB-DTPA: A Comparison in Healthy Volunteers

被引:75
|
作者
Brismar, T. B. [1 ]
Dahlstrom, N. [2 ,3 ]
Edsborg, N.
Persson, A. [3 ]
Smedby, O. [3 ,4 ]
Albiin, N.
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Radiol, SE-14186 Stockholm, Sweden
[2] Hudiksvall Hosp, Dept Radiol, Hudiksvall, Sweden
[3] Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden
[4] Linkoping Univ, Dept Radiol IMH, Linkoping, Sweden
关键词
Contrast dynamics; Gd-BOPTA; Gd-EOB-DTPA; liver; MRI; GADOBENATE DIMEGLUMINE; CLINICAL-EVALUATION; CONTRAST AGENTS; PHARMACOKINETICS; SAFETY; MRI;
D O I
10.1080/02841850903055603
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: A thorough understanding of magnetic resonance (MR) contrast media dynamics makes it possible to choose the optimal contrast media for each investigation. Differences in visualizing hepatobiliary function between Gd-BOPTA and Gd-EOB-DTPA have previously been demonstrated, but less has been published regarding differences in liver vessel visualization. Purpose: To compare the liver vessel and liver parenchymal enhancement dynamics of Gd-BOPTA (MultiHance) and Gd-EOB-DTPA (Primovist). Material and Methods: The signal intensity of the liver parenchyma, the common hepatic artery, the middle hepatic vein, and a segmental branch of the right portal vein was obtained in 10 healthy volunteers before contrast media administration, during arterial and portal venous phases, and 10, 20, 30, 40, and 130 min after intravenous contrast medium injection, but, due to scanner limitations, not during the hepatic venous phase. The doses of contrast media were 0.1 mmol/kg for Gd-BOPTA and 0.025 mmol/kg for Gd-EOB-DTPA. Results: Maximum enhancement of liver parenchyma was observed from the portal venous phase until 130 min after Gd-BOPTA administration and from 10 min to 40 min after Gd-EOB-DTPA. There was no difference in maximum enhancement of liver parenchyma between the two contrast media. When using Gd-BOPTA, the vascular contrast enhancement was still apparent 40 min after injection, but had vanished 10 min after Gd-EOB-DTPA injection. The maximum difference in signal intensity between the vessels and the liver parenchyma was significantly greater with Gd-BOPTA than with Gd-EOB-DTPA (P<0.0001). Conclusion: At the dosage used in this study, Gd-BOPTA yields higher maximum enhancement of the hepatic artery, portal vein, and middle hepatic vein during the arterial and the portal venous phase and during the delayed phases than Gd-EOB-DTPA does, whereas there is no difference in liver parenchymal enhancement between the two contrast agents.
引用
收藏
页码:709 / 715
页数:7
相关论文
共 50 条
  • [1] A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA
    Runge, VM
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1998, 22 (04) : 643 - 650
  • [2] Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects
    Dahlstrom, N.
    Persson, A.
    Albiin, N.
    Smedby, O.
    Brismar, T. B.
    ACTA RADIOLOGICA, 2007, 48 (04) : 362 - 368
  • [3] Comparison of Gd-Bz-TTDA, Gd-EOB-DTPA, and Gd-BOPTA for dynamic MR imaging of the liver in rat models
    Jaw, Twei-Shiun
    Chen, Shih-Hsien
    Wang, Yun-Ming
    Hsu, Jui-Sheng
    Kuo, Yu-Ting
    Chiu, Yen-Yu
    Tsai, Kun-Bow
    Hsieh, Tsyh-Jyi
    Liu, Gin-Chung
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2012, 28 (03): : 130 - 137
  • [4] Comparison of the Enhancement Pattern of Hepatic Hemangioma on Magnetic Resonance Imaging Performed With Gd-EOB-DTPA Versus Gd-BOPTA
    Vernuccio, Federica
    Bruno, Alberto
    Costanzo, Vincenzo
    Bartolotta, Tommaso Vincenzo
    Vieni, Salvatore
    Midiri, Massimo
    Salvaggio, Giuseppe
    Brancatelli, Giuseppe
    CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2020, 49 (06) : 398 - 403
  • [5] Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA [Aktueller stand der MRT-diagnostik mit leberspezifischen kontrastmitteln: Gd-EOB-DTPA und Gd-BOPTA]
    Stroszczynski C.
    Gaffke G.
    Gnauck M.
    Streitparth F.
    Wieners G.
    Lopez-Häninnen E.
    Der Radiologe, 2004, 44 (12): : 1185 - 1191
  • [6] Response to Letter: Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of HCA From FNH
    Thomeer, Maarten G.
    Vanhooymissen, Inge J. S. M. L.
    Braun, Loes M. M.
    van Koeverden, Sebastiaan
    Willemssen, Francois E.
    De Man, Robert A.
    Ijzermans, Jan N.
    Dwarkasing, Roy S.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 52 (04) : 1281 - 1282
  • [7] Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study
    O. Dahlqvist Leinhard
    N. Dahlström
    J. Kihlberg
    P. Sandström
    T. B. Brismar
    Ö. Smedby
    P. Lundberg
    European Radiology, 2012, 22 : 642 - 653
  • [8] Current status of MRI diagnostics with liver-specific contrast agents.: Gd-EOB-DTPA and Gd-BOPTA
    Stroszczynski, C
    Gaffke, G
    Gnauck, M
    Streitparth, F
    Wieners, G
    Lopez-Häninnen, E
    RADIOLOGE, 2004, 44 (12): : 1185 - 1191
  • [9] Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study
    Leinhard, O. Dahlqvist
    Dahlstrom, N.
    Kihlberg, J.
    Sandstrom, P.
    Brismar, T. B.
    Smedby, O.
    Lundberg, P.
    EUROPEAN RADIOLOGY, 2012, 22 (03) : 642 - 653
  • [10] Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia
    Vanhooymissen, Inge J. S. M. L.
    Thomeer, Maarten G.
    Braun, Loes M. M.
    Gest, Bibiche
    van Koeverden, Sebastiaan
    Willemssen, Francois E.
    Hunink, Myriam
    De Man, Robert A.
    Ijzermans, Jan N.
    Dwarkasing, Roy S.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 49 (03) : 700 - 710